| Literature DB >> 25493631 |
Nuno Martinho1, Helena Florindo1, Liana Silva1, Steve Brocchini2, Mire Zloh3, Teresa Barata4.
Abstract
Molecular modeling techniques provide a powerful tool to study the properties of molecules and their interactions at the molecular level. The use of computational techniques to predict interaction patterns and molecular properties can inform the design of drug delivery systems and therapeutic agents. Dendrimers are hyperbranched macromolecular structures that comprise repetitive building blocks and have defined architecture and functionality. Their unique structural features can be exploited to design novel carriers for both therapeutic and diagnostic agents. Many studies have been performed to iteratively optimise the properties of dendrimers in solution as well as their interaction with drugs, nucleic acids, proteins and lipid membranes. Key features including dendrimer size and surface have been revealed that can be modified to increase their performance as drug carriers. Computational studies have supported experimental work by providing valuable insights about dendrimer structure and possible molecular interactions at the molecular level. The progress in computational simulation techniques and models provides a basis to improve our ability to better predict and understand the biological activities and interactions of dendrimers. This review will focus on the use of molecular modeling tools for the study and design of dendrimers, with particular emphasis on the efforts that have been made to improve the efficacy of this class of molecules in biomedical applications.Entities:
Year: 2014 PMID: 25493631 PMCID: PMC6270869 DOI: 10.3390/molecules191220424
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structural properties of dendrimers; (A) Divergent synthesis; (B) Convergent synthesis; (C) Different topological structures that can be obtained from synthesis.
Figure 2Topological structures obtained with different core and branching monomers; From top to bottom: monomeric units, 2D structure of a G2 dendrimer, 3D structure of G2 dendrimer.
Figure 3Biomedical applications where MD has been important to probe biological interactions.
Figure 4Example of the dotted cap notation for a poly(aspartic acid) dendrimer; The dendrimer is represented by the core, branches and capping groups; This type of notation is useful since several capping groups with different branching points can be easily compared.
Figure 5Strategy employed for building dendrimers of different types and generations using XPLOR [71].
Examples of software used to build and simulate different types of dendrimers; * NA: the software was not disclosed; § Free use; ƚ Commercial use.
| Dendrimer Type | Software for Dendrimer Construct | Software Used for Simulations | Force Field | Aim of the Study |
|---|---|---|---|---|
| Conformational analysis | ||||
| PAMAM G2 to G6 [ | Insight II | Insight II ƚ CHARMM ƚ | CVFF CHARMM | Structural features at different pH and generations |
| PAMAM G5 [ | NA* | MPsim | DREIDING | Effect of pH to study the water dynamics on dendrimers |
| PAMAM G50% and 90% acetylated [ | Insight II | AMBER8 ƚ | GAFF | Effect of acetylation on structural features |
| Glycosylated PAMAM G3.5 [ | XPLOR | Desmond § | OPLS_2005 | Effect of glycosylation on structural features |
| Triazine G3 and G5 with DOTA terminals [ | AMBER 11 | AMBER 11 ƚ | GAFF and parm99 | Location of DOTA groups complexed with Gd ions |
| PEgylated PAMAM G3 to G5 [ | NA * | GROMACS § | MARTINI | Effect of PEGylation on the structure and interparticle interaction |
| Pegylated triazine dendrimers linked with paclitaxel [ | Material Studio 5 | AMBER 11 ƚ | parm99 | Effect of PEGylation on availability of linkers |
| Carboxylic modified PAMAM G5 with gold, fluorescein isothiocyanate (FI) and folic acid (FA) [ | Insight II | Insight II ƚ | CVFF | Conformation and location of FI and FA |
| PAMAM G5 with amine, carboxyl and acetamide groups linked to fluorescein and folic acid [ | Insight II | Insight II ƚ | CVFF | Location of folic acid and its availability |
| PAMAM G5 with methotrexate [ | CHARMM | CHARMM ƚ | CHARMM | Location of MTX when directly linked or with a spacer |
| Poly( | Starmaker (Silico) | NAMD § | OPLS-AA | Comparison of dendrimer architectures in solution |
| Dendrimer-small molecule interactions | ||||
| PAMAM G5 with different terminal
| Insight II | Insight II ƚ | CVFF | Influence of terminal groups on the complexation |
| PAMAM G4 + polyphenols [ | ChemOffice Ultra 6.0 | HyperChem Pro 7.0 ƚ | MM+ | Free binding energies |
| PAMAM G3 + nicotinic acid, nicotinate and 3-pyridiniumcarboxylate [ | HyperChem | NAMD § | CHARMM27 | Free energy of binding and the effect of pH variation on binding |
| Peptide dendrimers + hydroxypyrene trisulfonate butyrate ester [ | CORINA | GROMACS § | GROMOS-96 43a1 | Conformation and docking site location |
| PAMAM G5-Folic acid + Morphine and Tramadol [ | ICM | NAMD § | CHARMM 27; ParamChem | Different pHs; Binding mechanism elucidadtion; Location of folic acid |
| PAMAM G5 + salicylic acid, L-alanine, phenylbutazone, primidone [ | DBT/AMBER | AMBER9 ƚ | GAFF | Effect of pH on interaction and relation with drug release |
| Poly( | ChemBioOffice | Desmond § | OPLS-AA | Complex formation |
| Dendrimer-nucleic acid interaction | ||||
| Triazine G2dendrimers + siRNA or DNA [ | AMBER 10 | AMBER 10 ƚ | Parm99 | Binding mechanism and energy contributions |
| PAMAM ssDNA [ | AMBER 7 | AMBER 7 ƚ | AMBER 95 (DNA) DREIDING (dendrimer) | Binding interaction and energy contributions |
| PAMAM G3 DNA [ | NA * | NAMD § | CHARMM 27 | Complexation mechanism |
| PAMAM G0 and G1 + siRNA [ | Material Studio 5 | AMBER9 ƚ | Ff99 FF for RNA GAFF for dendrimers | Effects of pH on the complexation |
| PAMAM G7 + siRNA [ | Material Studio 5 | AMBER10 ƚ | GAFF (non-standard residues); parm99 | Complex interaction |
| Dendrimer-protein interaction | ||||
| Glycosylated PAMAM G3.5 + MD-2 protein [ | XPLOR | Desmond § | OPLS_2005 | Docking and interaction between active and non-active forms |
| PAMAM G4 Albumin [ | NA * | NA * | DREIDING | Contact points between dendrimer-albumin at physiological pH |
| PAMAM G0 with guanidinium terminal groups α-chymotrypsinogen A [ | NA * | NAMD § | CHARMM 27 | Site of interaction with the protein and effect of salt types |
| Dendrimer-lipid bilayer interaction | ||||
| Acetylated and non-acetylated PAMAM G5 and G7 + DMPC [ | Insight II | GROMACS § | MARTINI and adapted MARTINI | Effect of size, charge and concentration on dendrimer-membrane interaction |
| PAMAM G3 and G5 with different acetylation levels + DPPC [ | Insight II | GROMACS § | MARTINI | Effect of size, charge and lipid phase on dendrimer-membrane interaction |
| PAMAM G3 with amine, acetyl and carboxyl terminals + DMPC [ | CHARMM | CHARMM ƚ | CHARMM27 (lipid) and CHARMM 22 (dendrimer) | Effect of terminal groups and lipid phase |
Figure 6Docking strategies applied to dendrimer studies. Depending on the size either the dendrimer or the biomolecule can be described as the docking center. The docking site can be defined either in a small space of the dendrimer or in the whole structure (middle figures). The generated docking structures can then be submitted to MD simulations or the conformations from MD simulations can be used to dock the molecules (Bottom figures).
Non exhaustive list of PAMAM dendrimer simulations and their radius of gyration. For comparison the experimental values obtained by SAXS and SANS are displayed on top.
| FF | Solvent | G0 | G1 | G2 | G3 | G4 | G5 | G6 | G7 | G8 | G9 | G10 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Methanol | 15.8 | 17.1 | 24.1 | 26.3 | 31.9 | 40.3 | 49.2 | 57.4 | [ | ||||
| Methanol | 4.0 | 7.9 | 11.8 | 15.09 | 18.60 | 23.07 | 27.50 | 32.11 | 38.58 | - | - | [ | |
| D2O | - | - | - | - | 20.90–21.30 | - | - | - | - | - | - | [ | |
| D2O pH 4.97–10.25 | - | - | - | - | 20.64–21.58 | - | - | - | - | - | - | [ | |
| D2O pH 4.7–10.1 | - | - | - | - | - | - | - | - | 38.1–40.7 | - | - | [ | |
| Different solvents | - | - | - | - | - | 22.1 | - | - | 32.8–43.8 | - | - | [ | |
| Vacuum | 4.93 | 7.46 | 9.17 | 11.23 | 14.50 | 18.34 | 22.40 | 29.09 | 36.42 | 46.03 | 55.19 | [ | |
| Water explicit | - | - | - | - | 21.07–22.11 | - | - | - | - | - | - | [ | |
| Water implicit | 4.97 | 7.03 | 9.77 | 13.01 | 16.36 | 21.67 | 27.62 | - | - | - | - | [ | |
| Water explicit High pH | - | 7.4 | 11.5 | 12.9 | 16.9 | 20.3 | 24.7 | 30.1 | - | - | - | [ | |
| Water explicit Low pH | - | 9.4 | 13.6 | 17.2 | 21.1 | 26.1 | 32.5 | 37.57 | - | - | - | [ | |
| Water explicit | - | - | - | 15.33 | 21.04 | 25.50 | 30.18 | - | - | - | - | [ | |
| Water explicit pH 7.4 | - | - | - | 16.25 | 18.8–20 | 22.43–22.9 | 27.2 | - | - | - | - | [ | |
| Water explicit pH 5 | - | - | - | - | 21.0 | 24.2 | 28.9 | - | - | - | - | [ | |
| Water explicit pH 4–12 | - | - | - | - | - | - | - | 37.8–43.11 | - | - | [ | ||
| Water explicit | - | - | - | - | 20.1 | 25.6 | - | - | - | - | - | [ | |
| Water explicit | - | - | - | 13.1 | - | 23.20 | - | - | - | - | - | [ | |
| Water explicit pH 12 | - | - | - | - | 16.78 | 20.67 | 26.76 | - | - | - | - | [ | |
| Water explicit pH 7 | - | - | - | - | 17.01 | 22.19 | 27.28 | - | - | - | - | [ | |
| Water explicit pH 4 | - | - | - | - | 19.01 | 24.76 | 30.89 | - | - | - | - | [ | |
| Water implicit Low pH | - | - | 16.6 | 22.8 | 29.9 | 38.0 | 46.8 | - | - | - | - | [ | |
| Water implicit Neutral pH | - | - | 14.5 | 19.7 | 26.7 | 32.8 | 41.3 | - | - | - | - | [ | |
| Water implicit High pH | - | - | 8.4 | 11.6 | 14.8 | 18.3 | 24.2 | - | - | - | - | [ | |
| Vacuum | - | - | 11.0 | 13.7 | - | - | - | - | - | - | - | [ |
Figure 7Availability of the substituted terminal glucosamine groups on PAMAMs’ surface. Reprinted from [90].
Figure 8Proposed mechanism for high generation of PAMAM dendrimers; there is an initial attraction to the membrane governed by several forces (e.g., electrostatic); once the dendrimer is near the membrane the inner leaflet promotes interactions with the dendrimer. For high generation, the dendrimer is not able to flat and causes perturbation on the membrane leading to the formation of a vesicle encasing the dendrimers with subsequent formation of a pore.
Figure 9PAMAM dendrimers’ hydrophilic surface (blue) and hydrophobic core (orange). Adapted from [45].
Figure 10Docking between Dendrimer glucosamine and MD-2 protein and inhibition of TLR4-MD-2-LPS complex formation; adapted from [52].